News
Milan, 12 September 2023
AAVantgarde Appoints Dr. Doug Kerr to the Board of Directors
Milan, 6 June 2023
AAVantgarde closes €61 Million Series a financing to advance two Therapeutic Programs into the Clinic
Milan, 8 September 2022
AAVantgarde Bio appoints Dr. Natalia Misciattelli as Chief Executive Officer
Milan, 30 June 2022
AAVantgarde announces the appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer
Milan, 30 June 2021
Aavantgarde Bio receives seed funding from Sofinnova Partners
Milan, 30 March 2022